https://www.selleckchem.com/pr....oducts/epacadostat-i
, after adjustment for confounders, differences were no longer significant. Not only patients with diabetes but also patients with prediabetes represent a high-risk population. After treatment with new-generation DES, both patient groups had higher risks of ischemic and bleeding events. Differences in major bleeding were mainly attributable to dissimilarities in baseline characteristics. Routine assessment of glycemic state may help to identify patients with prediabetes for intensified management of cardiovascular risk fa
Like
Comment
Share
